Literature DB >> 7444367

Analysis of plasma bile acid profiles in patients with liver diseases associated with cholestasis.

A Bremmelgaard, B Almé.   

Abstract

Bile acids in plasma of patients with intra- or extra-hepatic cholestasis have been analyzed by gas chromatography-mass spectrometry after fractionation into groups by mode of conjugation. During cholestasis plasma concentrations ranged from 14 to 252 mumol/l. The predominant bile acid was cholic acid, comprising 44% to 89% of total bile acids. Tetrahydroxy- and trihydroxy-cholanoates with a tentative 6-hydroxy structure were identified, whereas 1-hydroxylated bile acids were not found. 3 beta-Hydroxy-5-cholenoic acid was the most important monohydroxycholanoate, comprising up to 13% of total bile acids in serum. The ratio of cholic to chenodeoxycholic acid in patients with primary biliary cirrhosis was in all cases more than 1. With the exception of 1-hydroxylated bile acids the main bile acids in urine an plasma were the same. Renal clearance of individual conjugated and sulfated bile acids could be calculated for some of the patients, assuming insignificant metabolism of bile acids in the kidney. The renal clearance of cholic acid conjugates tended to be higher tna that of chenodeoxycholic acid conjugates, and sulfates of cholic acid conjugates tended to have a higher renal clearance than sulfates of chenodeoxycholic acid conjugates. The clearance of sulfated 3 beta-hydroxy-5-cholenoic acid was still smaller. Chenodeoxycholic acid predominated in two healthy persons. Unconjugated bile acids accounted for 30% and 53%, respectively, of total bile acids. Sulfates of lithocholic, allolithocholic, and 3 beta-hydroxy-5-cholenoic acids were found after stimulation with a test meal.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7444367     DOI: 10.3109/00365528009182221

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  13 in total

1.  Cholecystectomy in patients with normal gallbladder function did not alter characteristics in duodenal motility which was not correlated to size of bile acid pool.

Authors:  P V Andersen; J Mortensen; E Oster-Jørgensen; L Rasmussen; S A Pedersen; N Qvist
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

2.  p53-mediated regulation of bile acid disposition attenuates cholic acid-induced cholestasis in mice.

Authors:  Pan Chen; Dongshun Li; Yixin Chen; Jiahong Sun; Kaili Fu; Lihuan Guan; Huizhen Zhang; Yiming Jiang; Xi Li; Xuezhen Zeng; Xiao Chen; Min Huang; Huichang Bi
Journal:  Br J Pharmacol       Date:  2017-10-22       Impact factor: 8.739

3.  Measurement of conjugated and unconjugated serum bile acid concentrations using 3 alpha-hydroxysteroid dehydrogenase.

Authors:  S M Smith; M Myszor; K D Setchell; G M Murphy
Journal:  J Clin Pathol       Date:  1983-02       Impact factor: 3.411

Review 4.  The role of CYP3A4 in the biotransformation of bile acids and therapeutic implication for cholestasis.

Authors:  Jiezhong Chen; Kong-Nan Zhao; Chen Chen
Journal:  Ann Transl Med       Date:  2014-01

5.  Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis.

Authors:  S Teng; M Piquette-Miller
Journal:  Br J Pharmacol       Date:  2007-04-16       Impact factor: 8.739

6.  Bile acid profile and decrement rate of serum total bilirubin after biliary drainage.

Authors:  T Kosuge; T Beppu; S Iwasaki; T Itoh; Y Idezuki
Journal:  Gastroenterol Jpn       Date:  1990-12

7.  Clinical evaluation of serum 3 beta-hydroxy-5-cholenoic acid in hepatobiliary diseases.

Authors:  K Sugiyama; S Okuyama; M Imoto; K Okumura; K Takagi; T Satake
Journal:  Gastroenterol Jpn       Date:  1986-12

8.  Determination of individual serum bile acids in chronic liver diseases: fasting levels and results of oral chenodeoxycholic acid tolerance test.

Authors:  Y Adachi; T Nanno; T Itoh; Y Kurumi; K Yamazaki; Y Sawada; T Yamamoto
Journal:  Gastroenterol Jpn       Date:  1988-08

9.  Lithocholate glucuronide is a cholestatic agent.

Authors:  D G Oelberg; M V Chari; J M Little; E W Adcock; R Lester
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

10.  Diurnal changes in serum unconjugated bile acids in normal man.

Authors:  K D Setchell; A M Lawson; E J Blackstock; G M Murphy
Journal:  Gut       Date:  1982-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.